Affiliation:
1. Tan Tock Seng Hospital, Singapore
Abstract
Coronavirus 2019 (COVID-19) vaccination remains one of the key public health measures against the SARS-CoV-2 infection, significantly reducing illness severity and mortality rates. Urticaria and/or angioedema are cutaneous reactions that have been reported in response to messenger RNA (mRNA) COVID-19 vaccination and potentially affect fitness for revaccination.1 The development of chronic spontaneous urticaria (CSU) post-COVID-19 vaccination2 may further discourage patients from revaccination or preclude revaccination to keep vaccinations updated. We describe a Singapore case series of 64 patients with urticaria post-COVID-19 vaccination, studying patient tolerance to revaccination, immunological profile and development of CSU.
Publisher
Academy of Medicine, Singapore
Reference9 articles.
1. Bellinato F, Maurelli M, Gisondi P, et al. Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines. J Clin Med 2021;10:5344.
2. Duperrex O, Tommasini F, Muller YD. Incidence of Chronic Spontaneous Urticaria Following Receipt of the COVID-19 Vaccine Booster in Switzerland. JAMA Netw Open 2023;6:e2254298.
3. Centers for Disease Control and Prevention. Allergic Reactions after COVID-19 Vaccination. Updated 14 December 2023. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/ allergic-reaction.html. Accessed 4 April 2023.
4. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2022;77:734-66.
5. Lim XR, Chan GYL, Tan JWL, et al. Anaphylatoxin Complement 5a in Pfizer BNT162b2-Induced Immediate-Type Vaccine Hypersensitivity Reactions. Vaccines (Basel) 2023;11:1020.